Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 23

1.

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.

Vosjan MJ, Perk LR, Roovers RC, Visser GW, Stigter-van Walsum M, van Bergen En Henegouwen PM, van Dongen GA.

Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):753-63. doi: 10.1007/s00259-010-1700-1. Epub 2011 Jan 6.

2.

Antibody vectors for imaging.

Olafsen T, Wu AM.

Semin Nucl Med. 2010 May;40(3):167-81. doi: 10.1053/j.semnuclmed.2009.12.005. Review.

3.

Antibodies and antimatter: the resurgence of immuno-PET.

Wu AM.

J Nucl Med. 2009 Jan;50(1):2-5. doi: 10.2967/jnumed.108.056887. Epub 2008 Dec 17. Review.

4.

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.

J Nucl Med. 2008 May;49(5):788-95. doi: 10.2967/jnumed.107.048538. Epub 2008 Apr 15.

5.

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Perik PJ, Lub-De Hooge MN, Gietema JA, van der Graaf WT, de Korte MA, Jonkman S, Kosterink JG, van Veldhuisen DJ, Sleijfer DT, Jager PL, de Vries EG.

J Clin Oncol. 2006 May 20;24(15):2276-82.

PMID:
16710024
6.

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

Schechter NR, Wendt RE 3rd, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, Broemeling LD, Kim EE, Cox JD, Podoloff DA, Ang KK.

J Nucl Med. 2004 Oct;45(10):1683-7.

7.

Preclinical characterisation of 111In-DTPA-trastuzumab.

Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG.

Br J Pharmacol. 2004 Sep;143(1):99-106. Epub 2004 Aug 2.

8.

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

Gr├╝nwald V, Hidalgo M.

J Natl Cancer Inst. 2003 Jun 18;95(12):851-67. Review.

PMID:
12813169
9.

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.

Schechter NR, Yang DJ, Azhdarinia A, Kohanim S, Wendt R 3rd, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA.

Anticancer Drugs. 2003 Jan;14(1):49-56.

PMID:
12544258
10.

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L.

Cancer Res. 2002 Dec 15;62(24):7350-6.

11.
12.

Biology of HER2 and its importance in breast cancer.

Yarden Y.

Oncology. 2001;61 Suppl 2:1-13. Review.

PMID:
11694782
13.
14.

Single domain camel antibodies: current status.

Muyldermans S.

J Biotechnol. 2001 Jun;74(4):277-302. Review.

PMID:
11526908
15.

The basic biology of HER2.

Rubin I, Yarden Y.

Ann Oncol. 2001;12 Suppl 1:S3-8. Review.

PMID:
11521719
16.

Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.

Desmyter A, Decanniere K, Muyldermans S, Wyns L.

J Biol Chem. 2001 Jul 13;276(28):26285-90. Epub 2001 May 7.

17.

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies.

Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S.

FEBS Lett. 1997 Sep 15;414(3):521-6.

18.

Growth factor synthesis and human breast cancer progression.

Ethier SP.

J Natl Cancer Inst. 1995 Jul 5;87(13):964-73. Review.

PMID:
7629883
19.

Predictive value of EGF receptor in breast cancer.

Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U.

Lancet. 1988 Nov 26;2(8622):1258. No abstract available.

PMID:
2903994
20.

Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E.

Cancer Res. 1988 Jan 1;48(1):137-41.

Supplemental Content

Support Center